Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries EndorsedV. Aboyans, J-B Ricco, M-L E. L. Bartelink et al. -
Management of two major complications in the cardiac catheterisation laboratory: the no-reflow phenomenon and coronary perforationsMuller O, Windecker S, Cuisset T et al.
-
Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China)XL Yang, JX Li, DF Gu et al.
-
Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized TrialJF Iglesias, D Heg , M Roffi et al.
-
Validation of High-Risk Features for Stent-Related Ischemic Events as Endorsed by the 2017 DAPT GuidelinesY Ueki, A Karagiannis, C Zanchin et al.
-
Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery DiseaseJ Sjaarda, H Gerstein, M Chong et al. -
From Nonclinical Research to Clinical Trials and Patient-registries: Challenges and Opportunities in Biomedical Researchde la Torre Hernández JM, Edelman ER
-
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trialDavies JE, ORBITA investigators et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
